Concepts (131)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fontan Procedure | 10 | 2023 | 155 | 4.550 |
Why?
|
| Heart Defects, Congenital | 14 | 2023 | 1697 | 3.150 |
Why?
|
| Heart-Assist Devices | 6 | 2023 | 1171 | 1.700 |
Why?
|
| Heart Transplantation | 5 | 2023 | 908 | 1.680 |
Why?
|
| Cardiac Catheterization | 2 | 2020 | 687 | 1.040 |
Why?
|
| Liver Diseases | 3 | 2023 | 574 | 0.770 |
Why?
|
| Protein-Losing Enteropathies | 1 | 2020 | 19 | 0.740 |
Why?
|
| Cardiac Rehabilitation | 1 | 2020 | 23 | 0.730 |
Why?
|
| Heart Failure | 4 | 2023 | 2516 | 0.720 |
Why?
|
| Heterotaxy Syndrome | 1 | 2019 | 63 | 0.680 |
Why?
|
| Pulmonary Artery | 2 | 2020 | 499 | 0.670 |
Why?
|
| Down Syndrome | 2 | 2020 | 226 | 0.670 |
Why?
|
| Aorta | 2 | 2020 | 692 | 0.660 |
Why?
|
| Central Venous Pressure | 1 | 2018 | 28 | 0.660 |
Why?
|
| Echocardiography | 3 | 2020 | 1182 | 0.650 |
Why?
|
| Tricuspid Atresia | 1 | 2018 | 12 | 0.650 |
Why?
|
| Biological Products | 1 | 2021 | 274 | 0.640 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2020 | 314 | 0.640 |
Why?
|
| Arterial Switch Operation | 1 | 2018 | 19 | 0.630 |
Why?
|
| Shock | 1 | 2019 | 88 | 0.620 |
Why?
|
| Specialization | 1 | 2019 | 130 | 0.620 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2020 | 218 | 0.600 |
Why?
|
| Turner Syndrome | 1 | 2018 | 68 | 0.600 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2018 | 136 | 0.600 |
Why?
|
| Exercise Therapy | 1 | 2020 | 288 | 0.590 |
Why?
|
| Creatinine | 1 | 2018 | 531 | 0.560 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2021 | 1237 | 0.550 |
Why?
|
| Renal Insufficiency | 1 | 2018 | 321 | 0.520 |
Why?
|
| Glomerular Filtration Rate | 1 | 2018 | 602 | 0.510 |
Why?
|
| Disease Management | 1 | 2020 | 1052 | 0.500 |
Why?
|
| Survivors | 1 | 2019 | 1031 | 0.470 |
Why?
|
| Cardiology | 1 | 2019 | 530 | 0.440 |
Why?
|
| Education, Medical, Graduate | 1 | 2019 | 671 | 0.440 |
Why?
|
| Diagnostic Imaging | 1 | 2020 | 1162 | 0.420 |
Why?
|
| Tissue Engineering | 2 | 2011 | 269 | 0.410 |
Why?
|
| Polyurethanes | 1 | 2011 | 36 | 0.400 |
Why?
|
| Chromosome Aberrations | 1 | 2018 | 1960 | 0.380 |
Why?
|
| Liver Transplantation | 3 | 2023 | 1112 | 0.370 |
Why?
|
| Postoperative Complications | 3 | 2023 | 5542 | 0.360 |
Why?
|
| Polymers | 1 | 2011 | 223 | 0.360 |
Why?
|
| Palliative Care | 1 | 2020 | 2037 | 0.330 |
Why?
|
| Transposition of Great Vessels | 2 | 2020 | 124 | 0.310 |
Why?
|
| Internship and Residency | 1 | 2019 | 1375 | 0.310 |
Why?
|
| Pyrroles | 1 | 2011 | 576 | 0.300 |
Why?
|
| Postoperative Period | 2 | 2020 | 665 | 0.290 |
Why?
|
| Nanoparticles | 1 | 2011 | 554 | 0.280 |
Why?
|
| Retrospective Studies | 10 | 2023 | 37905 | 0.260 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2023 | 34 | 0.230 |
Why?
|
| Humans | 23 | 2023 | 261506 | 0.230 |
Why?
|
| Adult | 11 | 2023 | 77950 | 0.220 |
Why?
|
| Cyanosis | 1 | 2021 | 40 | 0.200 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 543 | 0.190 |
Why?
|
| Hemodynamics | 2 | 2023 | 935 | 0.190 |
Why?
|
| Tachycardia, Paroxysmal | 1 | 2020 | 9 | 0.190 |
Why?
|
| Models, Cardiovascular | 1 | 2021 | 202 | 0.190 |
Why?
|
| Child | 6 | 2022 | 29154 | 0.180 |
Why?
|
| Hydrodynamics | 1 | 2019 | 18 | 0.180 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2021 | 107 | 0.170 |
Why?
|
| Biocompatible Materials | 2 | 2011 | 202 | 0.170 |
Why?
|
| Iatrogenic Disease | 1 | 2020 | 183 | 0.170 |
Why?
|
| Adolescent | 7 | 2023 | 31252 | 0.170 |
Why?
|
| Treatment Failure | 1 | 2021 | 1391 | 0.160 |
Why?
|
| Heart Valves | 1 | 2018 | 66 | 0.160 |
Why?
|
| Young Adult | 4 | 2021 | 21445 | 0.150 |
Why?
|
| Patients | 1 | 2020 | 245 | 0.150 |
Why?
|
| Swine | 1 | 2021 | 1541 | 0.150 |
Why?
|
| Heart Ventricles | 2 | 2021 | 846 | 0.140 |
Why?
|
| Treatment Outcome | 4 | 2022 | 32848 | 0.140 |
Why?
|
| Comorbidity | 2 | 2021 | 2352 | 0.140 |
Why?
|
| Cause of Death | 1 | 2019 | 752 | 0.140 |
Why?
|
| Health Status | 1 | 2019 | 590 | 0.140 |
Why?
|
| Male | 7 | 2021 | 123000 | 0.140 |
Why?
|
| Hospital Mortality | 2 | 2020 | 1274 | 0.140 |
Why?
|
| Hypertension, Pulmonary | 1 | 2021 | 462 | 0.140 |
Why?
|
| Endothelial Cells | 1 | 2021 | 1048 | 0.130 |
Why?
|
| Monitoring, Physiologic | 1 | 2018 | 502 | 0.130 |
Why?
|
| Hospitalization | 2 | 2021 | 2083 | 0.120 |
Why?
|
| Materials Testing | 2 | 2011 | 116 | 0.120 |
Why?
|
| Risk Factors | 3 | 2021 | 17523 | 0.120 |
Why?
|
| Stents | 1 | 2020 | 1096 | 0.120 |
Why?
|
| Communication | 1 | 2020 | 876 | 0.110 |
Why?
|
| Curriculum | 1 | 2019 | 860 | 0.110 |
Why?
|
| Texas | 2 | 2020 | 6311 | 0.100 |
Why?
|
| Electrochemical Techniques | 1 | 2011 | 5 | 0.100 |
Why?
|
| Electric Conductivity | 1 | 2011 | 94 | 0.100 |
Why?
|
| Child, Preschool | 2 | 2018 | 16273 | 0.100 |
Why?
|
| Ear Cartilage | 1 | 2010 | 6 | 0.100 |
Why?
|
| Myoblasts | 1 | 2011 | 72 | 0.100 |
Why?
|
| Age Factors | 1 | 2019 | 5377 | 0.090 |
Why?
|
| Hair | 1 | 2009 | 42 | 0.090 |
Why?
|
| Female | 5 | 2021 | 141928 | 0.080 |
Why?
|
| Hemostatics | 1 | 2009 | 88 | 0.080 |
Why?
|
| Prostheses and Implants | 1 | 2010 | 295 | 0.080 |
Why?
|
| Keratins | 1 | 2009 | 330 | 0.080 |
Why?
|
| Disease Progression | 1 | 2019 | 6682 | 0.080 |
Why?
|
| Incidence | 1 | 2018 | 5673 | 0.080 |
Why?
|
| Infant | 2 | 2020 | 13310 | 0.070 |
Why?
|
| Time Factors | 1 | 2019 | 12926 | 0.070 |
Why?
|
| Middle Aged | 3 | 2021 | 86204 | 0.070 |
Why?
|
| Infant, Newborn | 1 | 2018 | 8223 | 0.060 |
Why?
|
| United States | 2 | 2021 | 15433 | 0.060 |
Why?
|
| Animals | 4 | 2021 | 59536 | 0.060 |
Why?
|
| Cell Line | 1 | 2011 | 5114 | 0.060 |
Why?
|
| Cardiac Output | 1 | 2023 | 194 | 0.050 |
Why?
|
| Diuretics | 1 | 2023 | 170 | 0.050 |
Why?
|
| Morbidity | 1 | 2023 | 397 | 0.050 |
Why?
|
| Patient Acuity | 1 | 2021 | 72 | 0.050 |
Why?
|
| Causality | 1 | 2021 | 178 | 0.050 |
Why?
|
| Medically Uninsured | 1 | 2021 | 102 | 0.050 |
Why?
|
| Symptom Assessment | 1 | 2021 | 267 | 0.040 |
Why?
|
| Mortality | 1 | 2021 | 343 | 0.040 |
Why?
|
| Rabbits | 2 | 2010 | 957 | 0.040 |
Why?
|
| Insurance Coverage | 1 | 2021 | 256 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 7222 | 0.030 |
Why?
|
| Global Health | 1 | 2021 | 657 | 0.030 |
Why?
|
| Kidney | 1 | 2023 | 2146 | 0.030 |
Why?
|
| Liver | 1 | 2023 | 2961 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 4314 | 0.020 |
Why?
|
| Chondrocytes | 1 | 2010 | 107 | 0.020 |
Why?
|
| Thrombin | 1 | 2010 | 99 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2023 | 9244 | 0.020 |
Why?
|
| Hydrogels | 1 | 2010 | 123 | 0.020 |
Why?
|
| Mice | 1 | 2011 | 34495 | 0.020 |
Why?
|
| Fibrinogen | 1 | 2010 | 205 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2009 | 568 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2023 | 12873 | 0.020 |
Why?
|
| Amino Acids | 1 | 2009 | 728 | 0.020 |
Why?
|
| Heart Rate | 1 | 2009 | 737 | 0.020 |
Why?
|
| Aged | 2 | 2021 | 70117 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2009 | 1145 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2009 | 1467 | 0.010 |
Why?
|